DOJ warns New York AG over dispute with NYU Langone on transgender treatments
The Department of Justice has warned New York Attorney General Letitia James regarding her dispute with NYU Langone Health over transgender treatments for minors.

The U.S. Department of Justice has issued a warning to New York Attorney General Letitia James concerning her ongoing dispute with NYU Langone Health over transgender medical treatments for minors.
Deputy Attorney General Todd Blanche communicated the warning to James, stating that the DOJ "will not sit idly by while you attempt to use your office to force harmful procedures on our most vulnerable population."
The dispute centers on NYU Langone Health's decision to stop providing certain transgender treatments to minors. James has been engaged in a legal fight with the medical institution over this policy change.
The DOJ's intervention represents a federal response to what it characterizes as state-level overreach in medical treatment decisions. The warning suggests potential federal action if James continues her current course regarding the hospital system.
NYU Langone Health's decision to discontinue certain transgender treatments for minors appears to have prompted James to take action through her office's authority as state attorney general. The specific nature of the treatments and the hospital's rationale for the policy change were not detailed in the available information.
The confrontation highlights ongoing tensions between different levels of government over transgender healthcare policies, particularly those involving minors.